Recent

% | $
Quotes you view appear here for quick access.

Cytori Therapeutics, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • rhdapeng rhdapeng Aug 10, 2009 9:06 AM Flag

    Quarter results are VERY GOOD

    OK the one time payment from Olympus helps with the ongoing losses, BUT actual product revenues and gross profit are down Q/Q. So they are not selling much new.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • fyi-
      SAN DIEGO (AP) -- Cytori Therapeutics Inc., which makes products used in adult stem cell harvesting and research, on Monday reported a narrower loss for the second quarter of the year on a boost in development revenue.

      Cytori said it lost $826,000, or 2 cents per share, compared with a loss of $8.4 million, or 33 cents per share, a year earlier. Revenue jumped to $8.5 million from $1.4 million.

      Analysts expected a loss of 15 cents per share and $2.8 million in revenue, according to Thomson Reuters.

      The company makes a line of products called StemSource, which are used to extract, freeze and apply adult stem cells taken from fat tissue. Cytori also makes the Celbrush needle.

 
CYTX
1.19+0.01(+0.85%)Mar 27 4:00 PMEDT